Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics

Journal of Applied Microbiology

Volumn 121, Issue 1, 2016, Pages 78-88

  Dini, C ^a   Bolla, P A ^a,b   de Urraza, P J ^a,b  

^a Center for Research and Development in Food Cryotechnology ^*  (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

combined therapy; enterohemorrhagic Escherichia coli; kefir; phage; probiotics

Indexed keywords

ASSAYS; CELLS; CYTOTOXICITY; ESCHERICHIA COLI;

CELL DAMAGE; CELL/B.E; COMBINED THERAPY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EPITHELIAL CELLS; FREEZE DRYING; HEP-2 CELLS; IN-VITRO; KEFIR; PROBIOTICS;

LOW TEMPERATURE DRYING;

PROBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; APOPTOSIS; BACTERIOPHAGE; BACTERIUM; BIOASSAY; CELLS AND CELL COMPONENTS; PATHOGEN; PROBIOTICS; TOXICITY;

APOPTOSIS; ARTICLE; BACTERIOPHAGE; CELL ADHESION; CONTROLLED STUDY; CYTOTOXICITY; ENTEROHEMORRHAGIC ESCHERICHIA COLI INFECTION; EPITHELIUM CELL; ESCHERICHIA COLI INFECTION; FREEZE DRYING; HEP 2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN;

ESCHERICHIA COLI;

EID: 85027942534     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.13124     Document Type: Article

References (47)

1. Alam, M., Akhter, M.Z., Yasmin, M., Ahsan, C.R. and Nessa, J. (2011) Local bacteriophage isolates showed anti-Escherichia coli O157:H7 potency in an experimental ligated rabbit ileal loop model. Can J Microbiol 57, 408–415.
2. Arqués, J.L., Rodríguez, E., Langa, S., Landete, J.M. and Medina, M. (2015) Antimicrobial activity of lactic acid bacteria in dairy products and gut: effect on pathogens. BioMed Res Int 2015, 9.
3. Boirivant, M. and Strober, W. (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23, 679–692.
4. Bolla, P.A., Serradell Mde, L., de Urraza, P.J. and De Antoni, G.L. (2011) Effect of freeze-drying on viability and in vitro probiotic properties of a mixture of lactic acid bacteria and yeasts isolated from kefir. J Dairy Res 78, 15–22.
5. Bolla, P.A., Carasi, P., Bolla, M.A., De Antoni, G.L. and Serradell, M.A. (2013a) Protective effect of a mixture of kefir-isolated lactic acid bacteria and yeasts in a hamster model of Clostridium difficile infection. Anaerobe 21, 28–33.
6. Bolla, P.A., Carasi, P., Serradell, M.D.L.A. and De Antoni, G.L. (2013b) Kefir-isolated Lactococcus lactis subsp. lactis inhibits the cytotoxic effect of Clostridium difficile in vitro. J Dairy Res 80, 96–102.
7. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S. and Brussow, H. eds. (2004) In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Chemother 48, 2558–2569.
8. Ching, J.C., Jones, N.L., Ceponis, P.J., Karmali, M.A. and Sherman, P.M. (2002) Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases. Infect Immun 70, 4669–4677.
9. Corr, S.C., Li, Y., Riedel, C.U., O'Toole, P.W., Hill, C. and Gahan, C.G.M. (2007) Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA 104, 7617–7621.
10. Delfederico, L., Hollmann, A., Martínez, M., Iglesias, N.G., De Antoni, G. and Semorile, L. (2006) Molecular identification and typing of lactobacilli isolated from kefir grains. J Dairy Res 73, 20–27.
11. Dini, C. and De Urraza, P.J. (2010) Isolation and selection of coliphages as potential biocontrol agents of enterohemorrhagic and Shiga toxin-producing E. coli (EHEC and STEC) in cattle. J Appl Microbiol 109, 873–887.
12. Dini, C. and de Urraza, P.J. (2013) Effect of buffer systems and disaccharides concentration on Podoviridae coliphage stability during freeze drying and storage. Cryobiology 66, 339–342.
13. Doyle, M.P., Beuchat, L.R. and Montville, T.J. (2001) Food Microbiology: Fundamentals and Frontiers. Washington, DC: ASM Press.
14. Eutamene, H. and Bueno, L. (2007) Role of probiotics in correcting abnormalities of colonic flora induced by stress. Gut 56, 1495–1497.
15. Fedorak, R.N. and Madsen, K.L. (2004) Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20, 146–155.
16. Fernebro, J. (2011) Fighting bacterial infections – future treatment options. Drug Resist Updat 14, 125–139.
17. Gamage, S.D., Strasser, J.E., Chalk, C.L. and Weiss, A.A. (2003) Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin. Infect Immun 71, 3107–3115.
18. Garrote, G.L., Abraham, A.G. and De Antoni, G.L. (2001) Chemical and microbiological characterisation of kefir grains. J Dairy Res 68, 639–652.
19. Grossmann, J., Mohr, S., Lapentina, E.G., Fiocchi, C. and Levine, A.D. (1998) Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. Am J Physiol 274, G1117–G1124.
20. Gu, J., Liu, Y., Yu, S., Wang, H., Wang, Q., Yi, Y., Zhu, F., Yu, X.J. et al. (2009) Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice. Microbes Infect 11, 835–841.
21. Hugo, A.A., Kakisu, E., De Antoni, G.L. and Perez, P.F. (2008) Lactobacilli antagonize biological effects of enterohaemorrhagic Escherichia coli in vitro. Lett Appl Microbiol 46, 613–619.
22. Jandu, N., Zeng, Z.J., Johnson-Henry, K.C. and Sherman, P.M. (2009) Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1. Microbiology 155, 531–540.
23. Jankowska, A., Laubitz, D., Antushevich, H., Zabielski, R. and Grzesiuk, E. (2008) Competition of Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells. J Biomed Biotechnol 2008, 357964.
24. Johnson, S. and Taylor, C.M. (2008) What's new in haemolytic uraemic syndrome? Eur J Pediatr 167, 965–971.
25. Jones, N.L., Islur, A., Haq, R., Mascarenhas, M., Karmali, M.A., Perdue, M.H., Zanke, B.W. and Sherman, P.M. (2000) Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol 278, G811–G819.
26. Kakisu, E., Bolla, P., Abraham, A.G., de Urraza, P. and De Antoni, G.L. (2013) Lactobacillus plantarum isolated from kefir: protection of cultured Hep-2 cells against Shigella invasion. Int Dairy J 33, 22–26.
27. Karmali, M.A., Gannon, V. and Sargeant, J.M. (2010) Verocytotoxin-producing Escherichia coli (VTEC). Vet Microbiol 140, 360–370.
28. Kimmitt, P.T., Harwood, C.R. and Barer, M.R. (2000) Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis 6, 458–465.
29. Kropinski, A.M., Mazzocco, A., Waddell, T.E., Lingohr, E. and Johnson, R.P. (2009) Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol 501, 69–76.
30. Mack, D.R., Ahrne, S., Hyde, L., Wei, S. and Hollingsworth, M.A. (2003) Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52, 827–833.
31. Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L. et al. (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580–591.
32. Masana, M.O., Leotta, G.A., Del Castillo, L.L., D'Astek, B.A., Palladino, P.M., Galli, L., Vilacoba, E., Carbonari, C. et al. (2010) Prevalence, characterization, and genotypic analysis of Escherichia coli O157:H7/NM from selected beef exporting abattoirs of Argentina. J Food Prot 73, 649–656.
33. Matsuda, T., Freeman, T.A., Hilbert, D.W., Duff, M., Fuortes, M., Stapleton, P.P. and Daly, J.M. (2005) Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Surgery 137, 639–646.
34. Medellin-Pena, M.J. and Griffiths, M.W. (2009) Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization. Appl Environ Microbiol 75, 1165–1172.
35. Minnaard, J., Humen, M. and Perez, P.F. (2001) Effect of Bacillus cereus exocellular factors on human intestinal epithelial cells. J Food Prot 64, 1535–1541.
36. Oelschlaeger, T.A. (2010) Mechanisms of probiotic actions – a review. Int J Med Microbiol 300, 57–62.
37. Ogawa, M., Shimizu, K., Nomoto, K., Takahashi, M., Watanuki, M., Tanaka, R., Tanaka, T., Hamabata, T. et al. (2001) Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits. Infect Immun 69, 1101–1108.
38. Ohland, C.L. and MacNaughton, W.K. (2010) Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 298, G807–G819.
39. Paul, V.D., Sundarrajan, S., Rajagopalan, S.S., Hariharan, S., Kempashanaiah, N., Padmanabhan, S., Sriram, B. and Ramachandran, J. (2011) Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection. BMC Microbiol 11, 195.
40. Rahal, E.A., Kazzi, N., Nassar, F.J. and Matar, G.M. (2012) Escherichia coli O157:H7-Clinical aspects and novel treatment approaches. Front Cell Infect Microbiol 2, 138.
41. Romanin, D., Serradell, M., González Maciel, D., Lausada, N., Garrote, G.L. and Rumbo, M. (2010) Down-regulation of intestinal epithelial innate response by probiotic yeasts isolated from kefir. Int J Food Microbiol 140, 102–108.
42. Shu, Q. and Gill, H.S. (2002) Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol 34, 59–64.
43. Spinale, J., Ruebner, R., Copelovitch, L. and Kaplan, B. (2013) Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol 28, 2097–2105.
44. Tanji, Y., Shimada, T., Fukudomi, H., Miyanaga, K., Nakai, Y. and Unno, H. (2005) Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. J Biosci Bioeng 100, 280–287.
45. Tien, M.T., Girardin, S.E., Regnault, B., Le Bourhis, L., Dillies, M.A., Coppee, J.Y., Bourdet-Sicard, R., Sansonetti, P.J. et al. (2006) Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176, 1228–1237.
46. Viscardi, M., Perugini, A.G., Auriemma, C., Capuano, F., Morabito, S., Kim, K.P., Loessner, M.J. and Iovane, G. (2008) Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC). Int J Antimicrob Agents 31, 152–157.
47. Wong, C.S., Jelacic, S., Habeeb, R.L., Watkins, S.L. and Tarr, P.I. (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342, 1930–1936.